DK0775117T3 - Fluorerede 2-nitroimidazolanaloge til påvisning af hypoxiske tumorceller - Google Patents

Fluorerede 2-nitroimidazolanaloge til påvisning af hypoxiske tumorceller

Info

Publication number
DK0775117T3
DK0775117T3 DK95927535T DK95927535T DK0775117T3 DK 0775117 T3 DK0775117 T3 DK 0775117T3 DK 95927535 T DK95927535 T DK 95927535T DK 95927535 T DK95927535 T DK 95927535T DK 0775117 T3 DK0775117 T3 DK 0775117T3
Authority
DK
Denmark
Prior art keywords
tumor cells
hypoxic tumor
fluorinated
detection
nitroimidazole
Prior art date
Application number
DK95927535T
Other languages
English (en)
Inventor
Michael Tracy
Andrew B Kelson
Paul Workman
Eric O Aboagye
Alexander D Lewis
Original Assignee
Stanford Res Inst Int
Cancer Res Campaign Tech
Univ Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int, Cancer Res Campaign Tech, Univ Glasgow filed Critical Stanford Res Inst Int
Application granted granted Critical
Publication of DK0775117T3 publication Critical patent/DK0775117T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
DK95927535T 1994-08-05 1995-07-31 Fluorerede 2-nitroimidazolanaloge til påvisning af hypoxiske tumorceller DK0775117T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28647794A 1994-08-05 1994-08-05
US08/458,178 US5721265A (en) 1994-08-05 1995-06-02 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
PCT/US1995/009611 WO1996004249A1 (en) 1994-08-05 1995-07-31 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells

Publications (1)

Publication Number Publication Date
DK0775117T3 true DK0775117T3 (da) 2002-05-21

Family

ID=26963851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95927535T DK0775117T3 (da) 1994-08-05 1995-07-31 Fluorerede 2-nitroimidazolanaloge til påvisning af hypoxiske tumorceller

Country Status (10)

Country Link
US (1) US5721265A (da)
EP (1) EP0775117B1 (da)
JP (1) JP3872511B2 (da)
AT (1) ATE209187T1 (da)
CA (1) CA2196900C (da)
DE (1) DE69524103T2 (da)
DK (1) DK0775117T3 (da)
ES (1) ES2165430T3 (da)
PT (1) PT775117E (da)
WO (1) WO1996004249A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6252087B1 (en) * 1992-11-19 2001-06-26 The Trustees Of The University Of Pennsylvania Nitroaromatic compounds for the detection of hypoxia
US6855828B1 (en) 1992-11-19 2005-02-15 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US20050026974A1 (en) * 1996-02-08 2005-02-03 Trustees Of The University Of Pennsylvania Detection of hypoxia
ES2123449B1 (es) 1997-03-06 1999-09-16 Univ Madrid Nac Educacion Procedimiento para la obtencion de imagenes y espectros del ph extracelular por resonancia magnetica con indicadores extrinsecos conteniendo 1h o 19f.
EP1009753B1 (en) * 1997-08-21 2005-04-20 Quark Biotech, Inc. Hypoxia-regulated genes
WO2000018723A1 (en) * 1998-09-25 2000-04-06 Monsanto Company Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
CA2379974C (en) * 1999-07-21 2011-10-25 The Trustees Of The University Of Pennsylvania Preparation of compounds useful for the detection of hypoxia
US7230115B1 (en) 1999-07-21 2007-06-12 The Trustees Of The University Of Pennsylvania Preparation of compounds useful for the detection of hypoxia
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
WO2001058434A2 (en) * 2000-02-14 2001-08-16 Novolytic, Inc. Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents
DE102005063244A1 (de) * 2005-12-21 2007-06-28 Eberhard-Karls-Universität Tübingen Modifiziertes 2-Nitroimidazol-Derivat
US9056136B2 (en) * 2006-10-06 2015-06-16 Natural Pharmacia International, Inc. Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
WO2008124651A2 (en) * 2007-04-05 2008-10-16 Siemens Medical Solutions Usa, Inc. Nitro-imidazole hypoxia imaging agents
EP2123620A1 (en) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
WO2010073126A2 (en) * 2008-12-22 2010-07-01 The Governors Of The University Of Alberta Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
CN101624392B (zh) * 2009-08-10 2014-07-09 北京师范大学 F-三唑环-聚乙二醇-2-硝基咪唑化合物及其制备方法
US9074129B2 (en) 2009-12-01 2015-07-07 University Of Virginia Patent Foundation Mechanochromic luminescent difluoroboron beta-diketonates
CN113501789B (zh) * 2021-06-16 2023-03-31 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 一种硝基咪唑类衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505349A (en) * 1966-04-18 1970-04-07 Hoffmann La Roche 2-nitro-imidazolyl-1-acetamides
US5304654A (en) * 1987-06-10 1994-04-19 Yasunori Nishijima Fluorine-containing nitroimidazole compounds
CA1329206C (en) * 1987-06-10 1994-05-03 Tsutomu Kagiya Fluorine-containing nitroazole derivatives and radiosensitizer comprising the same
IL92597A0 (en) * 1988-12-14 1990-08-31 Yasunori Nishijima President K Novel fluorine-containing 2-nitroimidazole derivatives and radiosensitizer comprising the same
EP0669913B1 (en) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Detection of hypoxia

Also Published As

Publication number Publication date
PT775117E (pt) 2002-05-31
ATE209187T1 (de) 2001-12-15
JPH10506104A (ja) 1998-06-16
EP0775117A1 (en) 1997-05-28
WO1996004249A1 (en) 1996-02-15
ES2165430T3 (es) 2002-03-16
CA2196900A1 (en) 1996-02-15
DE69524103T2 (de) 2002-07-18
CA2196900C (en) 2009-02-24
JP3872511B2 (ja) 2007-01-24
EP0775117B1 (en) 2001-11-21
US5721265A (en) 1998-02-24
DE69524103D1 (de) 2002-01-03

Similar Documents

Publication Publication Date Title
DK0775117T3 (da) Fluorerede 2-nitroimidazolanaloge til påvisning af hypoxiske tumorceller
MX9203165A (es) Derivados de succinimida y composicion farmaceutica que los contiene .
DE60027420D1 (de) Tri-aryl-säurederivate als ppar rezeptor liganden
EA200200360A1 (ru) Производные пурина
TR199902368T2 (xx) S�lfonamid t�revleri.
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
ATE301122T1 (de) Kernerweiterte perylenbisimide und ihre verwendung als fluoreszenzfarbstoffe
IT1152287B (it) Pirrolidin-derivati
ATE249440T1 (de) Flüssige benzisochinoline derivate
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
DK148183A (da) Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
EA199900163A1 (ru) Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
ES466850A1 (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-imi- dazolidinilidenbenzamina.
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
EA199900754A1 (ru) Способ получения замещенного тиазолидиндиона
DK0871612T3 (da) Kondenserede isoindoloner som proteinkinase C-inhibitorer
ATE153657T1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
FI913658A (fi) 4-amino-d4,6-steroider och deras anvaendning som 5a-reduktas-inhibitorer.
DK148804C (da) Fremgangsmaade til fremstilling af 1,2,3,4-tetrahydroquinolin-4-oner
FI872719A (fi) Nya tetrahydro-benzotiazoler, deras framstaellning och anvaendning.
AU519287B2 (en) Imidazo(1,2-alpha) imidazole derivatives
ES2043784T3 (es) Procedimiento de preparacion de compuestos guanidinicos.
DK0555283T3 (da) Mellemprodukter ved fremstillingen af 4,5-difluoranthranilinsyre